ASCIA Education Projects

ASCIA Anaphylaxis projects | ASCIA Food Allergy projects | ASCIA Respiratory/Insect Allergy projects | ASCIA Drug (Medication) Allergy projectsASCIA Skin/Allergy projects | ASCIA Immunodeficiency projects | ASCIA Testing resources | ASCIA COVID-19 resources  

The ASCIA team works with ASCIA members to continually update and develop accessible, consistent and evidence based resources, education and training, to support ASCIA members, their patients/carers, other health professionals and the community. 

In 2020 there were more than:

  • 20 new ASCIA resources developed (as listed below)
  • 40 ASCIA resources updated (as listed below)
  • 4,500 e-newsletters sent each month
  • 100,000 ASCIA e-training course registrations
  • 1.9 million ASCIA website visits
  • 3.3 million ASCIA website pageviews

 ASCIA Anaphylaxis projects 

The following recently completed resources will be promoted in 2021:

Updated 2021 versions of ASCIA Action Plans for Anaphylaxis (3), ASCIA Action Plan for Drug (Medication) Allergy, ASCIA Action Plan for Allergic Reactions and First Aid Plans for Anaphylaxis (3) www.allergy.org.au/anaphylaxis

Updated 2021 ASCIA Action Plan FAQ www.allergy.org.au/hp/anaphylaxis/action-plans-for-allergic-reactions-faq

Updated 2020 ASCIA Anaphylaxis Checklists www.allergy.org.au/hp/anaphylaxis/anaphylaxis-checklist

Updated 2020 ASCIA Guidelines - Acute Management of Anaphylaxis www.allergy.org.au/hp/papers/acute-management-of-anaphylaxis-guidelines 

New 2020 ASCIA Guidelines - Acute Management of Anaphylaxis in Pregnancy www.allergy.org.au/hp/papers/acute-management-of-anaphylaxis-in-pregnancy

New 2020 How Allergies Work animation www.allergy.org.au/patients/immune-system 

The following projects are scheduled to be completed in 2021:

  • New ASCIA anaphylaxis refresher e-training, a short course for trainers, schools, early childhood education/care (ECEC) and community - expected to be available by late July 2021.
  • Updated ASCIA anaphylaxis e-training for schools, children's education/care (CEC) and community - expected to be available by late July 2021.
  • Updated ASCIA anaphylaxis e-training for health professionals, including pharmacists - expected to be available by late July 2021.

ASCIA Food Allergy projects 

The following recently completed resources will be promoted in 2021:

New 2021 ASCIA Position Paper Oral Immunotherapy (OIT) for Food Allergy www.allergy.org.au/hp/papers/ascia-oral-immunotherapy-for-food-allergy

New 2021 ASCIA Oral Immunotherapy (OIT) for Food Allergy FAQ www.allergy.org.au/patients/allergy-treatment/oral-immunotherapy-for-food-allergy

New 2021 ASCIA Position Statement - Packaged Foods for Infants that Contain Most of the Common Food Allergens www.allergy.org.au/hp/papers/infant-feeding-products 

Updated 2020 ASCIA How to introduce solid foods for allergy prevention FAQ www.allergy.org.au/patients/allergy-prevention/ascia-how-to-introduce-solid-foods-to-babies

New 2020 ASCIA Guide for Milk Substitutes in Cow's Milk Allergy (for health professionals) www.allergy.org.au/hp/papers/guide-for-milk-substitutes-cows-milk-allergy

New 2020 ASCIA Fast Facts - Eczema and Food Allergy, Cow's Milk Allergy and Peanut Allergy www.allergy.org.au/patients/fast-facts

Updated 2020 ASCIA Egg Allergy and Influenza Vaccination information www.allergy.org.au/patients/food-allergy/egg-allergy-flu-vaccine  

Updated 2020 ASCIA Dietary Avoidance for Cow's Milk Allergy www.allergy.org.au/patients/food-allergy/ascia-dietary-avoidance-for-food-allergy

The following projects are scheduled to be completed in 2021:

  • Updated ASCIA Food Allergy FAQ
  • Updated ASCIA Dietary Guide FAQ
  • Updated ASCIA Food Allergy e-training and reference list - Course completion is expected by late July 2021. 
  • New ASCIA Action and Treatment Plans for Eosinophilic Oesophagitis (EoE)
  • New ASCIA FED2 and FED4 Dietary Guides for EoE

ASCIA Respiratory/Insect Allergy projects 

The following recently completed resources will be promoted in 2021:

New 2021 ASCIA Sublingual Immunotherapy (SCIT) Treatment Plan  

Updated 2021 ASCIA Subcutaneous Immunotherapy (SCIT) Treatment Plan www.allergy.org.au/hp/papers/scit-treatment-plan
 
New 2021 How to Safely Remove a Tick animation video www.allergy.org.au/patients/insect-allergy-bites-and-stings
 
Updated 2020 ASCIA Allergic Rhinitis Treatment Plan www.allergy.org.au/patients/allergic-rhinitis-hay-fever-and-

The following projects are scheduled to be completed in 2021:

  • Updated ASCIA Allergen Immunotherapy e-training for health professionals
  • New ASCIA Position Paper on Chronic Rhinosinusitis with Nasal Polyps
  • Updated ASCIA Allergic Rhinitis e-training for health professionals

ASCIA Drug (Medication) Allergy projects 

The following recently completed resources will be promoted in 2021:

Updated 2021 ASCIA Action Plan for Drug (Medication) Allergy www.allergy.org.au/hp/drug-allergy/ascia-action-plan-for-drug-medication-allergy

Updated 2021 ASCIA Record for Drug (Medication) Allergy www.allergy.org.au/hp/drug-allergy/ascia-record-for-drug-medication-allergy

New 2020 ASCIA Drug (Medication) Allergy Terms www.allergy.org.au/hp/drug-allergy/ascia-drug-medication-allergy-terms

Updated 2020 ASCIA Penicillin Allergy Consensus Statement www.allergy.org.au/members/ascia-penicillin-allergy-guidelines

The following projects are scheduled to be completed in early 2021:

  • New ASCIA Cephalosporin Allergy Consensus Statement 
  • Updated ASCIA Penicillin Allergy Guide 

ASCIA Skin/Allergy projects 

The following resources will be promoted in 2021:

New 2020 ASCIA Eczema and Food Allergy Fast Facts www.allergy.org.au/patients/fast-facts/eczema-and-food-allergy

Updated 2020 ASCIA Eczema Action Plan www.allergy.org.au/patients/skin-allergy/eczema-action-plan

Updated 2020 ASCIA Chronic Urticaria Position Statement and Treatment Guidelines www.allergy.org.au/hp/papers/chronic-spontaneous-urticaria-csu-guidelines

New 2020 What is Eczema? animation videos www.allergy.org.au/patients/skin-allergy

The following projects are scheduled to be completed in 2021:

ASCIA Immunodeficiency projects 

The following will be promoted in 2021:

New 2021 ASCIA Immunodeficiency Strategy for Australia and New Zealand www.nationalimmunodeficiencystrategy.org.au  

TAPID Collaboration www.allergy.org.au/about-ascia/ascia-initiatives/tapid

New 2020 ASCIA COVID-19 and Immunodeficiency Resources www.allergy.org.au/members/covid-19 

Updated 2020 HAE Position Paper and Management Plan www.allergy.org.au/hp/papers/hereditary-angioedema

ASCIA Immunodeficiency Register https://idregister.ascia.org.au/

The following projects are scheduled to be completed in 2021:

  • Launch and implementation of ASCIA Immunodeficiency Strategy www.nationalimmunodeficiencystrategy.org.au 
  • Updated ASCIA primary immunodeficiency (PID) e-training for health professionals 
  • New ASCIA immunoglobulin replacement therapy (IRT) e-training for health professionals 
  • New ASCIA hereditary angioedema (HAE) e-training for health professionals 
  • New ASCIA IRT Clinical Update for healthprofessionals, based on the new e-training course.
  • Updated ASCIA PID Clinical Update www.allergy.org.au/hp/papers/pid
  • ASCIA HAE patient information
  • New ASCIA immune system and immunodeficiency animations 

ASCIA Testing resources 

The following recently completed resources will be promoted in 2021:

New 2021 ASCIA Frequently Asked Questions (FAQ) - Evidence-Based Versus Non Evidence-Based Tests and Treatments for Allergic Disorders (for patients, consumers and carers) www.allergy.org.au/patients/allergy-testing/evidence-based-versus-non-evidence-based-tests-and-treatments 

New 2021 ASCIA Position Paper - Evidence-Based Versus Non Evidence-Based Tests and Treatments for Allergic Disorders (for health professionals) www.allergy.org.au/hp/papers/position-paper-evidence-based-versus-non-evidence-based-allergy-tests-and-treatments 

New 2021 ASCIA Reference List - Evidence-Based Versus Non Evidence-Based Tests and Treatments for Allergic Disorders www.allergy.org.au/hp/papers/refs-evidence-based-versus-non-evidence-based-allergy-tests-and-treatments 

New 2020 ASCIA Laboratory Investigation of Allergic Diseases www.allergy.org.au/hp/papers/tests-in-the-diagnosis-of-allergic-diseases

New 2020 Allergic Reactions Clinical History Form (with type in fields) www.allergy.org.au/hp/anaphylaxis/clinical-history-form-allergic-reactions

Updated 2020 Allergic Reactions Event Record (with type in fields) www.allergy.org.au/hp/anaphylaxis/anaphylaxis-event-record

ASCIA COVID-19 resources 

The following recently completed resources will be promoted in 2021:

New ASCA Frequently Asked Questions (FAQ) COVID-19 Vaccination (patients, consumers, carers) www.allergy.org.au/patients/ascia-covid-19-vaccination-faq 

New ASCA Position Statement COVID-19 Vaccination (health professionals)www.allergy.org.au/hp/papers/ascia-hp-position-statement-covid-19-vaccination

New ASCIA Guide Allergy and COVID-19 Vaccination (health professionals)www.allergy.org.au/hp/papers/guide-allergy-and-covid-19-vaccination

New ASCIA Guide Immunodeficiency, Autoimmunity and COVID-19 Vaccination (health professionals) www.allergy.org.au/hp/papers/guide-immunodeficiency-autoimmunity-and-covid-19-vaccination

ASCIA COVID-19 Resources webpage www.allergy.org.au/members/covid-19 

COVID-19 Frequently Asked Questions (FAQ) www.allergy.org.au/patients/covid-19#faq

Checklist: Actions to Reduce the Spread of COVID-19 www.allergy.org.au/patients/covid-19#list

COVID-19 and Immunodeficiency (Accessed more than 100,000 times from March to June 2020) www.allergy.org.au/patients/immunodeficiencies/covid-19-and-immunodeficiency
 

Content updated June 2021              

Mod ASCIA Member
Donate to AIFA
go to NAS website
ASCIA Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:

About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.